Biohaven Ltd.
NYSE:BHVNBiotechnology
Healthcare
$13.65 -1.62%
-$0.22 today
- Market cap
- $2.06B
- Beta
- 3.31
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$4.39
52W Low $7.48High $18.57
Volume 3.26M
Average 2.47M
Balance Sheet
Inspect the capital base behind the business.
Assets
$451.45M
FY 2025 · Annual
-26.6% YoYLiabilities
$399.38M
FY 2025 · Annual
+108.4% YoYEquity
$52.07M
FY 2025 · Annual
-87.7% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 76.06M | 204.88M | 248.4M | 99.13M | 229.96M |
| Short-term Investments | 0 | 260.46M | 133.42M | 386.86M | 89.18M |
| Net Receivables | 0 | 46.14M | 13.25M | 2.6M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 12.03M | 54.54M | 12.13M | 508K | 2.17M |
| Total Current Assets | 94.82M | 586.97M | 442.45M | 538.47M | 368.33M |
| Property, Plant & Equipment (Net) | 17.68M | 52.44M | 48.58M | 53.71M | 15.96M |
| Goodwill | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M |
| Intangible Assets | 18.95M | 18.4M | 18.4M | 18.4M | 18.4M |
| Long-term Investments | 6M | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 3.22M | 2.59M | 2.4M | 3.13M | 47.36M |
| Total Non-current Assets | 47.24M | 74.82M | 70.77M | 76.64M | 83.12M |
| Total Assets | 142.06M | 661.78M | 513.21M | 615.11M | 451.45M |
| Account Payables | 4.78M | 10.7M | 15.58M | 18.03M | 11.64M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 9.54M | 14.6M | 35.7M | 84.71M | 59.49M |
| Total Current Liabilities | 41.94M | 90.02M | 55.42M | 154.23M | 115.93M |
| Long-term Debt | 0 | 0 | 0 | 0 | 238.9M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.64M | 2.41M | 2.25M | 4.66M | 4.58M |
| Total Non-current Liabilities | 5.44M | 32.99M | 29.81M | 37.45M | 283.44M |
| Total Liabilities | 47.37M | 123.01M | 85.24M | 191.67M | 399.38M |
| Common Stock | 34.69M | 615.74M | 887.53M | 1.66B | 1.93B |
| Retained Earnings | 0 | (91.12M) | (499.29M) | (1.35B) | (2.08B) |
| Accumulated OCI | 0 | 284K | (65K) | 79K | 8.35M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 60M | 0 | 0 | 0 | 0 |
| Total Equity | 94.69M | 538.77M | 427.98M | 423.44M | 52.07M |
| Total Debt | 3.24M | 33.6M | 30.88M | 36.58M | 284.61M |
| Net Debt | (72.82M) | (171.28M) | (217.53M) | (62.55M) | 54.66M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $238.0M |
| Short-term Investments | $29.8M |
| Other Current | $28.7M |
| Total Current Assets | $296.6M |
| PP&E (Net) | $15.1M |
| Goodwill | $1.4M |
| Intangible Assets | $18.4M |
| Other Non-current | $39.3M |
| Total Non-current Assets | $74.2M |
| Total Assets | $370.7M |
Analysis
Selected assets total $370.7M for Latest. The largest visible component is Cash & Equivalents at $238.0M, about 64.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | |
| 8-K | Current report | Oct 29, 2026 | |
| 8-K | Current report | Oct 22, 2026 | |
| 8-K | Current report | Oct 15, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 17, 2026 |
How much cash does BHVN have?
Biohaven Ltd. (BHVN) reported $229.96M in cash and equivalents in fiscal 2025.
How much debt does BHVN carry?
Biohaven Ltd. (BHVN) reported $284.61M of total debt, with net debt of $54.66M.
Continue the stock analysis
Jump to another research area for this company.